Form 8-K - Current report:
SEC Accession No. 0000950170-25-087068
Filing Date
2025-06-17
Accepted
2025-06-17 08:00:29
Documents
12
Period of Report
2025-06-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtyx-20250617.htm   iXBRL 8-K 59140
2 EX-99.1 vtyx-ex99_1.htm EX-99.1 38713
3 GRAPHIC img90346216_0.jpg GRAPHIC 43599
  Complete submission text file 0000950170-25-087068.txt   275066

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vtyx-20250617.xsd EX-101.SCH 24847
14 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20250617_htm.xml XML 4712
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 251051851
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)